Stage T1c Prostate Cancer---A Heterogenous Category with Widely Varying Prognosis: P-29Hung, Arthur Y.Kuban, Deborah A.The Cancer Journal
F. Transforming growth factor beta 1 expression in human colorectal tumours: an independent prognostic marker in a subgroup of poor prognosis patients. Br. J. Cancer 74, 753–758 (1996). Article CAS PubMed PubMed Central Google Scholar Tsamandas, A. C. et al. The potential role of TGF...
For instance, they can be used as tools for the risk stratification, screening, and early detection of cancer. In addition, they can be used to inform diagnosis, prognosis, and response to therapy, as well as aid patient surveillance and monitoring [16, 17]. However, the proteomic analysis...
Lymphovascular Invasion Represents a Prognostic and Predictive Pathological Factor of the Duration of Adjuvant Chemotherapy for Stage III Colon Cancer Pati... Lymphovascular Invasion Represents a Prognostic and Predictive Pathological Factor of the Duration of Adjuvant Chemotherapy for Stage III Colon Cancer ...
Unchecked proliferation is a hallmark of cancer cells,6 but not all tumors grow at the same rate; the spectrum ranges from indolent to aggressive. The ability to determine the proliferation rate could provide important information about a patient’s prognosis and even guide therapeutic decisions. ...
3c). We identified a minimum number of samples to potentially apply meaningful machine learning, by varying training sample number from 20 to 280 (Fig. 3c), while the testing set size was also varied from 20 to 280 for the nonoverlapping sample splitting in training number optimization. The ...
According to The Human Protein Atlas, SIPA1L2 is a biomarker for renal cancer [53]. SIPA1L2 expression has also been associated with an unfavourable prognosis in intestinal-type gastric cancer [54]. SIPA1L2 is downregulated in colorectal cancer, and reduced SIPA1L2 expression is associated ...
Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease. J Urol 2010;184(1):114-9. PUBMED | CROSSREFReese AC, Cooperberg MR, Carroll PR. Minimal impact of clinical stage on prostate cancer prog- nosis among contemporary ...
The prognosis and prediction of adjuvant chemotherapy (ACT) response in early-stage non-small cell lung cancer (NSCLC) patients remain poor in this era of personalized medicine. We hypothesize that extracellular matrix (ECM)-associated components could b
prognosis [67,68]. These PCNA+proliferating TAMs in breast cancer also had high expression ofMKI67[69]. In the T cells, we identified a proliferating subtype that simultaneously express both effector T-cell and dysfunctional markers (Fig.3c). A recent research reported a highly proliferating ...